• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: FISHER & PAYKEL HEALTHCARE LTD FISHER & PAYKEL HEALTHCARE; NASAL CANNULA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

FISHER & PAYKEL HEALTHCARE LTD FISHER & PAYKEL HEALTHCARE; NASAL CANNULA Back to Search Results
Model Number OPT318
Medical Device Problem Code Break (1069)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 11/01/2023
Type of Reportable Event Malfunction
Event or Problem Description
A distributor reported on behalf of a healthcare facility in china that the tubing of an opt318 optiflow junior nasal cannula was found to be broken before use.There was no patient involvement.
 
Additional Manufacturer Narrative
(b)(4).Method: the complaint opt318 optiflow junior nasal cannula was not received at fisher & paykel healthcare (f&p) for investigation.Our investigation was thus based on the information, photograph and video provided by the customer and our knowledge on the product.Results: visual inspection of the provided photograph and video revealed that the tubing of the opt318 optiflow junior nasal cannula was damaged.Conclusion: without the complaint device, we are unable to determine the cause of the reported fault.All optiflow junior cannulas are 100% leak and occlusion tested after final assembly and any cannula that fails is discarded.Samples are also taken and pull tested to check the tube tensile strength and the glue joint strength at the cannula/tube joint, as well as the swivel grip joint.The subject cannula would have met the required specification at time of production.The user instructions which accompany the opt318 optiflow junior nasal cannula show in pictorial format the correct placement and fitting of the cannula and also warn: ensure that all connections are secure during use.Check cannula is undamaged and that the flow path is maintained.Under excessive load, the cannula may disconnect to prevent forces being transferred to the patient.Appropriate patient monitoring must be used at all times.Failure to monitor the patient may result in loss of therapy, serious injury or death.Do not stretch or crush tube.
 
Additional Manufacturer Narrative
(b)(4).**udi related data quality updates only** corrections to reflect gudid: section d1: brand name updated to fisher & paykel healthcare, section d2a: common device name updated to nasal cannula, section d2b: product code updated to btt, section d4: udi details updated - expiration date added, section g1: contact person updated to mr.(b)(4), section g4: pma/510(k) number updated to k162553.Method: the complaint opt318 optiflow junior nasal cannula was not received at fisher & paykel healthcare (f&p) for investigation.Our investigation was thus based on the information, photograph and video provided by the customer and our knowledge on the product.Results: visual inspection of the provided photograph and video revealed that the tubing of the opt318 optiflow junior nasal cannula was damaged.Conclusion: without the complaint device, we are unable to determine the cause of the reported fault.All optiflow junior cannulas are 100% leak and occlusion tested after final assembly and any cannula that fails is discarded.Samples are also taken and pull tested to check the tube tensile strength and the glue joint strength at the cannula/tube joint, as well as the swivel grip joint.The subject cannula would have met the required specification at time of production.The user instructions which accompany the opt318 optiflow junior nasal cannula show in pictorial format the correct placement and fitting of the cannula and also warn: ensure that all connections are secure during use.Check cannula is undamaged and that the flow path is maintained.Under excessive load, the cannula may disconnect to prevent forces being transferred to the patient.Appropriate patient monitoring must be used at all times.Failure to monitor the patient may result in loss of therapy, serious injury or death.- do not stretch or crush tube.
 
Event or Problem Description
A distributor reported on behalf of a healthcare facility in china that the tubing of an opt318 optiflow junior nasal cannula was found to be broken before use.There was no patient involvement.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FISHER & PAYKEL HEALTHCARE
Common Device Name
NASAL CANNULA
Manufacturer (Section D)
FISHER & PAYKEL HEALTHCARE LTD
15 maurice paykel place
east tamaki
auckland, 2013
NZ  2013
Manufacturer (Section G)
FISHER & PAYKEL HEALTHCARE LTD
15 maurice paykel place
east tamaki
auckland, 2013
NZ   2013
Manufacturer Contact
diego vargas banuelos
17400 laguna canyon road
suite 300
irvine, CA 92618
9494341005
MDR Report Key18379930
Report Number9611451-2023-01216
Device Sequence Number16843461
Product Code BTT
UDI-Device Identifier09420012432308
UDI-Public(01)09420012432308(10)2102560472(11)230324(17)260324
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
K162553
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,User Facility,Distributor
Initial Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date (Section B) 11/29/2023
2 Devices were Involved in the Event: 1   2  
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date03/24/2026
Device Model NumberOPT318
Device Catalogue NumberOPT318
Device Lot Number2102560472
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/29/2023
Supplement Date Received by Manufacturer11/29/2023
Initial Report FDA Received Date12/21/2023
Supplement Report FDA Received Date08/13/2024
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured03/24/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-